ASCO Education
American Society of Clinical Oncology (ASCO)
ASCO Education: By the Book features engaging discussions between editors and authors from the ASCO Educational Book. Hear nuanced views on topics featured in Education Sessions at ASCO meetings and deep dives on the approaches shaping modern oncology that have care teams talking.
Episodes
Mentioned books
May 9, 2018 • 7min
Adjuvant Treatment in Melanoma: Recent Advances
Dr. Rodrigo Munhoz, medical oncologist at Centro de Oncologia- Hospital Sírio-Libanês in Sao Paolo, Brazil, discusses recent advances in the adjuvant therapy for patients with high-risk melanoma
May 2, 2018 • 5min
Recently Approved Drugs: Blinatumomab for B-cell precursor ALL
Alex Ganetsky, PharmD, BCOP, oncology clinical pharmacy specialist at the Hospital of the University of Pennsylvania in Philadelphia discusses the approval to blinatumomab (Blincyto, Amgen Inc.) for the treatment of adult and pediatric patients with B-cell precursor acute lymphoblastic leukemia (ALL) in first or second complete remission with minimal residual disease (MRD) greater than or equal to 0.1%.
Apr 25, 2018 • 16min
Guidelines: Management of Immune-Related Adverse Events
An interview with Dr. Bryan Schneider of the University of Michigan on the ASCO clinical practice guideline to increase awareness, outline strategies, and offer guidance on the recommended management of immune-related adverse events in patients treated with immune checkpoint inhibitor (ICPi) therapy. Read the full guideline at www.asco.org/supportive-care-guidelines
Apr 18, 2018 • 8min
Treatment Effects & Transition to Survivorship for AYA Patients
Cindy Schwartz, MD, MPH, is an accomplished oncologist who brings 35 years of experience, passion and expertise in the areas of Hodgkin lymphoma, osteosarcoma and childhood cancer survivorship.
Apr 11, 2018 • 6min
EHR Chemotherapy Error: Breast Cancer
Dr. Carolyn Hendricks is a board certified medical oncologist specializing in breast cancer. She received her medical degree from Johns Hopkins University School of Medicine and has been in practice for more than 20 years.
Apr 4, 2018 • 5min
Continuity of Care for AYAs
Dr. Larissa Nekhlyudov is a board-certified general internist and Medical Director of Primary Care Associates, Longwood. Dr. Nekhlyudov practiced internal medicine at Harvard Vanguard Medical Associates for over 15 years. In this episode she discusses the importance of effective communication between the primary care physician & oncologist for AYA patients diagnosed with cancer.
Mar 28, 2018 • 4min
Self-Evaluation: Clinical Trials Informed Consent Process
Dr. Suresh Ramalingam, professor of hematology and medical oncology at Emory University and Deputy Director at the Winship Cancer Institute of Emory University, presents a self-evaluation question on Clinical Trials: Informed Consent
Mar 14, 2018 • 4min
Self-Evaluation: Clinical Trials
Dr. Suresh Ramalingam, professor of hematology and medical oncology at Emory University and Deputy Director at the Winship Cancer Institute of Emory University, presents a self-evaluation question on clinical research methodologies, clinical trials, phase III.
Feb 14, 2018 • 4min
Self-Evaluation: NSCLC
Dr. Benjamin Levy, Clinical Director at the Johns Hopkins Sidney Kimmel Cancer Center at the Sibley Memorial Hospital in Washington, D.C., presents a self-evaluation questions on non-small cell lung cancer.
Feb 7, 2018 • 5min
Self-Evaluation: Breast Cancer
Dr. Shaheenah Dawood, consultant medical oncologist and lead of the oncology research program at the Comprehensive Cancer Center Mediclinic City Hospital in the United Arab Emirates, presents a self-evaluation question on the predictive and prognostic rule of pathological complete response attained in the treatment of breast cancer.
